Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Marker Therapeutics, Inc. (MRKR)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5M | $6.6M | $3.3M | $3.5M | $1.2M | $466,785 | $213,194 | $205,994 | $183,064 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $11.8M | $13.5M | $10.4M | $12.0M | $27.8M | $18.9M | $12.8M | $8.0M | $5.3M | $3.8M | $1.7M | $189,000 | $697,634 | $1.1M | $203,725 | $290,048 | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $16.4M | $17.7M | $17.9M | $23.3M | $40.7M | $29.4M | $22.7M | $148.4M | $11.7M | $8.5M | — | — | — | $6.2M | $3.3M | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | −$12.9M | −$11.1M | −$14.6M | −$19.8M | −$39.5M | −$28.9M | −$22.5M | −$148.2M | −$11.5M | −$8.5M | −$6.2M | −$3.4M | −$2.7M | — | −$3.3M | −$5.5M | — | — | — | — | — | — | — | — | — | — |
| EBITDAderived | — | — | — | −$17.0M | −$37.3M | −$28.4M | −$22.4M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$12.2M | −$10.7M | −$8.2M | −$29.9M | −$41.9M | −$28.7M | −$21.4M | −$148.0M | −$11.0M | −$2.5M | −$34.1M | −$30.9M | −$5.5M | −$5.9M | −$2.0M | −$3.5M | −$17.3M | −$2.2M | −$3.9M | −$1.3M | −$985,599 | −$2.7M | −$5.8M | −$2.3M | −$671,986 | −$935,332 |
| Basic EPSper diluted share | -$0.79 | -$1.19 | -$0.94 | -$3.58 | -$5.47 | -$0.61 | -$0.47 | -$7.75 | -$1.16 | -$0.36 | -$9.30 | -$2.00 | -$4.87 | -$9.42 | -$0.04 | -$0.09 | — | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$0.79 | -$1.19 | -$0.94 | -$3.58 | -$5.47 | -$0.61 | -$0.47 | -$7.75 | -$1.16 | -$0.72 | -$9.30 | -$2.00 | -$4.87 | -$9.42 | -$0.04 | -$0.09 | — | — | — | — | — | — | — | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 23, 2024Form 4 | ELMS STEVEDirector | BuyCommon Stock · indirect | 11.1K | $3.20 | $35.5K | 325.4K |
| Dec 23, 2024Form 4 | NEA Partners 16, L.P. +9TenPercentOwner | BuyCommon Stock | 554.3K | $3.20 | $1.77M | 1.63M |